MétaCan
Menu
Back to cohort
Record W4386953678 · doi:10.1093/bjs/znad304

Comment on: Two decades of surgical randomized controlled trials: worldwide trends in volume and methodological quality

2023· letter· en· W4386953678 on OpenAlexaff
Xiya Ma, Dominique Vervoort

Bibliographic record

VenueBritish journal of surgery · 2023
Typeletter
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmaceutical industry and healthcare
Canadian institutionsUniversity of TorontoUniversité de Montréal
Fundersnot available
KeywordsMedicineRandomized controlled trialVolume (thermodynamics)MEDLINEQuality (philosophy)Intensive care medicineMedical physicsSurgery

Abstract

fetched live from OpenAlex

Dear Editor RCTs represent the gold standard for evidence generation. Pronk et al.1 reviewed surgical RCTs over a span of 20 years, finding an improvement in trial quality along with a rise in Asia, mostly led by China. Pronk et al.1 focused on progress in reported methodology and study design, but did not consider improvements in terms of equity and, consequently, the generalizability of current trials, which ought to be considered a form of quality. Inequity may present at the trialist level and among patients enrolled in RCTs, both commonly disproportionately dominated by white men in high-income countries. Pronk et al.1 showed that, despite some geographical shift, only one lower-middle-income country (Egypt) was featured in the top 10 in terms of trial volume in 2019, whereas Africa and South America together represented the smallest number of trials at 6.8 per cent of the total volume, despite being home to nearly one-quarter of the world’s population. This challenges the generalizability of trials, as interventions that work within a given country or region do not account for cultural, political, and economical factors that may influence behaviours and outcomes elsewhere. Further, under-enrolment of women and minoritized and racialized populations has been found among trials in high-income countries. Thus, even results within the same country may be difficult to generalize to its entire population. Barriers to improving equity in RCTs are manifold, including high costs, complex logistics, long timelines, and difficulties with data infrastructure and follow-up, which render these opportunities less accessible to researchers in variable-resource contexts, where context-appropriate evidence is especially highly needed. Moreover, imbalances in trialist networks perpetuate biases that result in under-enrolment of under-represented populations. Future directions should include increased mentorship and collaboration to empower early-career trialists, more representative trial teams, and more pragmatic and lower-cost solutions to RCTs. Xiya Ma (Conceptualization, Writing—original draft, Writing—review & editing), and Dominique Vervoort (Conceptualization, Methodology, Supervision, Writing—original draft, Writing—review & editing).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.046
metaresearch head score (Gemma)0.267
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.954
Threshold uncertainty score0.242

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0460.267
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0050.004
Bibliometrics0.0030.005
Science and technology studies0.0060.008
Scholarly communication0.0080.006
Open science0.0050.004
Research integrity0.1150.062
Insufficient payload (model declined to judge)0.0080.011

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.754
GPT teacher head0.619
Teacher spread0.134 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
DomainMethods
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractno

Explore more

Same venueBritish journal of surgerySame topicPharmaceutical industry and healthcareFrench-language works237,207